Missing/wrong data?
Log in to edit
High-dose CD34+ cells are not clinically relevant in reducing cytopenia and blood component consumption following myeloablative therapy and peripheral blood progenitor cell transplantation as compared with standard dose
scientific article published on 01 April 2002
Author/s
author: Vincent Levy, Raphaël Porcher, Marina Cavazzana, Olivier Hermine, Agnès Buzyn, Françoise Audat, François Lefrère, Coralie Belanger
Work details
Publication date
April 1, 2002
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.